Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -171.72% is 52% above its 5-year average of -356.83%, near the high end of its 5-year range (-1018.14%–-131.41%).
43.28% above its 12-month average of -302.76%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -384.21%.
NET PROFIT MARGIN
-171.72%
NET PROFIT MARGIN AVG TTM
-302.76%
NET PROFIT MARGIN AVG 3Y
-335.76%
NET PROFIT MARGIN AVG 5Y
-356.83%
NET PROFIT MARGIN AVG 10Y
-326.30%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+43.28%
CURRENT VS 3Y AVG
+48.86%
CURRENT VS 5Y AVG
+51.88%
CURRENT VS 10Y AVG
+47.37%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-65946.15%
vs the sector median at left
Profound Medical Corp.
Market Cap
$220.93M
Net Profit Margin
-171.72%
TTM Avg
-302.76%
3Y Avg
-335.76%
5Y Avg
-356.83%
Market Cap
$218.30M
Net Profit Margin
-553.88%
TTM Avg
-2620.95%
3Y Avg
-26640.28%
5Y Avg
-17808.90%
Market Cap
$216.91M
Net Profit Margin
-269.75%
TTM Avg
-1318.17%
3Y Avg
-659.09%
5Y Avg
-439.39%
Market Cap
$225.24M
Net Profit Margin
-29747.89%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$215.07M
Net Profit Margin
74.06%
TTM Avg
51.52%
3Y Avg
44.79%
5Y Avg
47.28%
Market Cap
$214.46M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$227.60M
Net Profit Margin
-26.97%
TTM Avg
-50.02%
3Y Avg
-94.39%
5Y Avg
-87.59%
Market Cap
$214.24M
Net Profit Margin
12.39%
TTM Avg
11.00%
3Y Avg
-1.71%
5Y Avg
-13.45%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Profound Medical Corp. (PROF) | $220.93M | -171.72% | -302.76% | -335.76% | -356.83% |
| Keros Therapeutics, Inc. (KROS)vs › | $218.30M | -553.88% | -2620.95% | -26640.28% | -17808.90% |
| Prelude Therapeutics Incorporated (PRLD)vs › | $216.91M | -269.75% | -1318.17% | -659.09% | -439.39% |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $225.24M | -29747.89% | 0.00% | 0.00% | 0.00% |
| Anbio Biotechnology Class A Ordinary Shares (NNNN)vs › | $215.07M | 74.06% | 51.52% | 44.79% | 47.28% |
| Sionna Therapeutics, Inc. (SION)vs › | $214.46M | 0.00% | 0.00% | 0.00% | 0.00% |
| Biodesix, Inc. (BDSX)vs › | $227.60M | -26.97% | -50.02% | -94.39% | -87.59% |
| Niagen Bioscience Inc (NAGE)vs › | $214.24M | 12.39% | 11.00% | -1.71% | -13.45% |
| Vogenx Inc. (VOGX)vs › | $227.91M | N/A | N/A | N/A | N/A |
| Lyell Immunopharma, Inc. (LYEL)vs › | $210.98M | -920285.19% | -662320.41% | -376335.80% | -251721.50% |
Operating Margin
-256.3%
Net Profit Margin
-171.7%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -384.21% |
| 2026-03-31 | -132.15% |
| 2025-12-31 | -136.77% |
| 2025-09-30 | -150.82% |
| 2025-06-30 | -709.86% |
| 2025-03-31 | -409.16% |
| 2024-12-31 | -131.41% |
| 2024-09-30 | -330.69% |
| 2024-06-30 | -309.85% |
| 2024-03-31 | -457.61% |
| 2023-12-31 | -431.21% |
| 2023-09-30 | -321.99% |
| 2023-06-30 | -459.11% |
| 2023-03-31 | -368.76% |
| 2022-12-31 | -757.92% |
| 2022-09-30 | -245.55% |
| 2022-06-30 | -292.84% |
| 2022-03-31 | -602.27% |
| 2021-12-31 | -1018.14% |
| 2021-09-30 | -236.34% |
| 2021-06-30 | -268.10% |
| 2021-03-31 | -1054.71% |
| 2020-12-31 | -205.40% |
| 2020-09-30 | -272.97% |
| 2020-06-30 | -516.86% |
| 2020-03-31 | -231.29% |
| 2019-12-31 | -188.96% |
| 2019-09-30 | -919.04% |
| 2019-06-30 | -1017.95% |
| 2019-03-31 | -198.31% |
| 2018-12-31 | -240.70% |
| 2018-09-30 | -1691.00% |
| 2018-06-30 | -2733.18% |
| 2018-03-31 | -1312.18% |
| 2017-12-31 | -239.57% |
| 2017-09-30 | -374.75% |
| 2017-06-30 | -374.23% |
| 2017-03-31 | -521.63% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
